Antibody heteroconjugates and bispecific antibodies for use in r

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435332, 435334, 53038875, 5303911, 530405, 5303873, C12N 500, C12N 502, C07K 1600, C12P 2108

Patent

active

060109025

ABSTRACT:
The present invention relates to novel antibody heteroconjugates and bispecific antibodies and methods and compositions and their use in the enhancement or inhibition of activation and function of T or B lymphocytes. The heteroconjugates are comprised of at least two antibody molecules cross-linked to each other, each molecule being reactive with a different lymphocyte antigen on the same cell. The invention also provides bispecific antibodies comprising a first binding region reactive with an antigen on a lymphocyte and a second binding region reactive with a different antigen on the lymphocyte. The heteroconjugates, bispecific antibodies, methods and compositions of this invention are therefore useful in the regulation of lymphocyte function, resulting in the improvement of cellular immune responses in various disease states.

REFERENCES:
patent: 4381292 (1983-04-01), Bieber et al.
patent: 4676980 (1987-06-01), Segal
V. Ghetie & I. Moraru, "Preparation and Applications of Multivalent Antibodies with Dual Specificity," Meth. Enzymol. 92:523-543 (1983).
Kimball, Ed., Intro to Immunol. 2nd Ed., Chpt. 11-13, MacMillan Pub. Co. (1986).
Reinherz et al., "Clonotypic Surface Structure on Human T Lymphocytes: Functional and Biochemical Analysis of the Antigen Receptor Complex", Immunol. Rev.81:95-129 (1984).
Emmrich et al., "Cross-Linking of the T-Cell Receptor Complex with the Subset-Specific Differentiation Antigen Stimulates Interleukin 2 Receptor Expression in Human CD4 and CD8 T Cells", Eur. J. Immunol. 17:529-34 (1987).
Anderson et al., "Cross-Linking of T3 (CD3) with T4 (CD4) Enhances the Proliferation of Resting T Lymphocytes" J. Immunol.,139(No.3) 678-83 (1987).
McMichael, Ed., (Cobbold) Leukocyte Typing III, Oxford Univ. Press, Oxford, U.K., (1987), Chpt. 15, pp. 788-803.
Ledbetter et al., Perspectives in Immunogen. and Histocompatibility, vol. 6, Heise, Ed., "Lymphocyte Surface Antigens" (1984), pp. 325-340 (N.Y. 1984).
Yamada et al., "Monoclonal Antibody 9.3 and Anti-CD11 Antibodies Define Reciprocal Subsets of Lymphocytes", Eur. J. Immunol, 15:1164-1169 (1985).
Imboden et al., "Transmembrane Signalling by the T Cell Antigen Receptor" J. Exp. Med., 161:446-56 (1985).
Imboden et al., "Antigen Recognition by a Human T Cell Clone Leads to Increases in Inositol Triphasphate" J. Immunol. 103(No.5): 1322-24 (1987).
Walker et al., "Activation of T Cells by Cross-Linking an Anti-CD3 Antibody with a Second Anti-T Cell Antibody: Mechanism and Subset-Specific Activation", Eur. J. Immunol. 17:873-80 (1987).
Ledbetter et al., "Valency of CD3 Binding and Internaliztion of the CD3 Cell-Surface Complex Control T Cell Responses to Second Signals", J. Immunol., 136:3945-52 (1986).
Marrack et al., "The Major Histocompatibility Complex Restricted Antigen REceptor on T Cells II. Role of the L3T4 Product", J. Exp. Med., 158:1077-91 (1983).
Gay et al., "Functional Interaction Between Human T Cell Protein CD4 and the Major Histocompatibility Complex HLA-DR Antigen" Nature, 328:626-29 (1987).
Regnier-Vigruroux et al., "Accessory Molecules and T Cell Activation I. Antige Receptor Avidity Differentially Influences T Cell Sensitivity to Inhibition by Monoclonal Antibodies to LFA-1 and L3T4", Eur. J. Immunol., 16:1385-90 (1986).
Shaw et al., "Susceptibility of Cytotoxic T Lymphocyte (CTL) Clones to Inhibition by Anti-T3 and Anti-T4 (But not Anti-LF-1) Monoclonal Antibodies Varies with the Avidity of CTL-Target Interaction", J. Immunol. 134(No.5): 3019-26 (1985).
Bank et al., "Perturbation of the T4 Molecule Transmits A Negative Signal to the T Cells" J. Exp. Med., 162:1294 (1985).
Tite et al., "The Role of L3T4 in T Cell Activation: L3T4 May be Both An Ia-Binding Protein and a Receptor That Transduces a Negative Signal" J. Cell Mol. Immunol., 2:179-90 (1986).
Rosoff et al., "The Role of the L3T4 Molecule in Mitogen and Antigen Activated Signal Transduction" Cell. 49:845-53 (1987).
Trowbridge et al., "Differences in the Surface Proteins of Mouse B and T Cells" Proc. Natl. Acad. Sci. USA 72:157-161 ( 1975).
Komuro et al., "Ly-5: A new T-Lymphocyte Antigen System", Immunogenetics 1:452-456 (1975).
Schied et al., "Further Description of the Ly-5 System", Immunogenetics, 9:423-433 (1979).
Dalchau et la., "Monoclonal Antibodies to a Human Leukocyte-Specific Membrane Glycoprotein Probably Homologous to the Leukocyte-Common (L-C) Antigen of the Rat", Eur. J. Immunol, 10:737-744 (1980).
Omary et al., "Human Homologue of Murine T200 Glycoprotein", J. Exp. Med., 152:842-852 (1980).
Dalchau et al., "Identification with a Monoclonal Antibody of a Predominantly B Lymphocyte-Specific Determinant of the Human Leukocyte Common Antigen", J. Exp. Med. 153:753-765 (1981).
Morimoto et al., "The Isolation and Characterization of the Human Suppressor Inducer T Cell Subset", J. Immunol., 134:1508-1515 (1985).
Ledbetter et al., "Antibodies to Common Leukocyte Antigen p220 Influence Human T Cell Proliferation by Modifying IL 2 Receptor Expression", J. Immunol., 135: 1819-1825 (1985).
Smith et al., "Functional Subset of Human Helper-Inducer Cells Defined by a New Monoclonal Antibody UCHL1", Immunol., 58:63-70 (1986).
Thomas et al., "Evidence from cDNA Clones that The Rat Leukocyte-Common Antigen (T200) Spans the Lipid Bilayer and Contains A Cytoplasmic Domain of Mr", Cell, 41:83-93 (1985).
Barclay et al., "Lymphocyte specific Heterogeneity in the Rat Leukocyte Common Antigen (T200) is Due to Differences in Polypeptide Sequences near the NH2-Terminus", EMBO J., 6:1259-1264 (1987).
Saga et al., "Sequences of LY-5 cDNA: Isoform-Related Diversity of LY-5-mRNA" Proc. Natl. Acad. Sci. USA, 83:6940-6944 (1986).
Raschke, "Cloned Murine T200 (Lv-5) cDNA reveals Multiple Transcripts within B-and T-Lymphocyte Lineages", Proc. Natl. Acad. Sci. USA,84:161-165 (1987).
Thomas et al., "B-Cell Variant of Mouse T200 (Ly-5): Evidence for alternative mRNA spicing", Proc. Natl. Acad. Sci. USA 84:5360-5363 (1987).
Saga et al., "Alternative Use of 5' Exons in The Specification of Ly-5 Isoforms Distinguishing Hematopoietic Cell Lineages", Proc. Natl. Acad. Sci. USA, 84:5364-5368 (1987).
Ralph et al., "Structural Variants of Human T200 Glycoprotein (Leukocyte-Common Antigen)", EMBO J.,6:1251-1257 (1987).
Streuli et al., "Differential Usage of Three Exons Generates at Least Five Different mRNAs Encoding Human Leukocyte Common Antigens", J. Exp. Med., 166:1548-1566 (1987).
Harp et al., "Inhibition of T Cell Responses to Alloantigens and Polyclonal Mitogens by Ly-5 Antisera" J. Immunol., 133:10-15 (1984).
Bernabeu et al., "Interaction Between the CD45 Antigen and Phytohemagglutinin Inhibitory Effect on the Lectin-Induced T Cell Proliferation by anti-CD45 Monoclonal Antibody", Eur. J. Immunol., 17:1461-1466 (1987).
Mittler et al., "Antibodies to the Common Leukocyte Antigen (T200) Inhibit an Early Phase in the Activation of Resting Human B Cells", J. Immunol., 138:3159-3166 (1987).
Yakura, "On the Function of Ly-5 In the Regulation of Antigen-Driven B Cell Differentiation", J. Exp. Med., 157:1077-1088 (1983).
Seaman et al., "Surface Antigens on Mouse Natural Killer Cells: Use of Monoclonal Antibodies to Inhibit or to Enrich Cytotoxic Activity" J. Immunol., 127:982-986 (1981).
Newman , "Selective Blockade of Human Natural Killer Cells by a Monoclonal Antibody", Proc. Natl. Acad. Sci USA 79:3858-3862 (1982).
Makavama et al., "Cytotoxic T Cells Lyt Phenotype and Blocking of Killing Activity by Lyt Antisera", Proc. Natl. Acad. Sci. USA, 76:1977-1981 (1979).
LeFrancois et al., "Functional Modifications of Cytotoxic T-Lymphocyte T200 Glycoprotein Recognized by Monoclonal Antibodies", Nature (London) 314:449-452 (1985).
Martorell et al., "A Second Signal for T Cell Mitogenosis Provided by Monoclonal Antibodies", Eur. J. Immunol. 17:1447-1451 (1987).
Tonks et al., "Purification of the Major Protein-Tyrosine-Phosphatases of Human Placenta", J. Biol. Chem., 263:6722-6730 (1990).
Charbonneau et al., "The Leukocyte Common Antigen (CD45): A Putative Receptor-Linked Protein Tyrosine Phosphatase", Proc. Natl. Acad. Sci. USA, 85:7182-7186 (1988).
Kunfer et al., "Cocluste

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibody heteroconjugates and bispecific antibodies for use in r does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody heteroconjugates and bispecific antibodies for use in r, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody heteroconjugates and bispecific antibodies for use in r will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1072026

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.